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VITAMIN D METABOLITE CONCENTRATIONS AND CLINICAL PARAMETERS IN CROHN 'S DISEASE
Concentrations of plasma 25-(OH)D3 (mean± 1 SD) were significantly lower in patients with active disease (25X3+1X0 nmol/1, n=11) compared with patients who had inactive disease (39.3±18*3 nmol/ 1, n=29) -p<O005. There was also a significant inverse correlation between serum orosomucoid concentrations and 25-(OH)D3 (Fig. 2) . Otherwise, 25-(OH)D3 and the two dihydroxylated metabolites were not affected by clinical parameters, and results were not significantly different between patients on and off steroids. 
25(OH)D3
Corrected calcium and serum phosphate were both normal and similar between the four groups. Undernourished Crohn's patients, however, had significantly increased total alkaline phosphatase activity compared with the other three groups (p<OO1) (Fig. 3) . Well nourished Crohn's patients and ulcerative colitis patients, however, also had mean levels higher than normal subjects (p<005). Eleven No subject in the study had symptoms or signs of osteomalacia. Calcium and phosphate concentrations were always normal, but the majority of patients in the undernourished Crohn's group had raised alkaline phosphatase concentrations, largely from bone. In previous work27 high alkaline phosphatase levels were attributed to liver disease, but this study did not include details of isoenzymes to alkaline phosphatase nor measurements of 5-nucleotidase or gamma glutamyl transferase, so their conclusions about the prevalence of bone disease are open to discussion. More substantial evidence for osteomalacia would require bone biopsy, but this was not thought to be justified on a group of patients who were on the whole asymptomatic. Clearly, however, osteomalacia is now recognised to be more common than previously suspected in Crohn's disease and may exist without clinical or biochemical abnormalities. 2829 We conclude that undernourished patients with Crohn's disease, who may be identified by simple measurements of the midarm circumference, have reduced vitamin D levels compared with nourished patients and a control population, and that one of the principal determinants of this low vitamin D status is an increased disease activity. These patients should avoid drugs such as cholestyramine which 
